Further, p-ezrin enhances NHE1 activity at invadopodia, invadopodial-dependent ECM proteolysis and cell invasion, thus inducing an invasive phenotype in breast cancer cells in vitro by coordinating an ECM proteolytic/invasion signal module. The gene discussed is SLC9A1; the disease is breast carcinoma.